Savara to Present Key Research on Rare Lung Disease at ERS Congress 2025
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) announced that three of its abstracts have been accepted for poster presentation at the European Respiratory Society (ERS) Congress 2025, taking place September …
Savara to Present Key Research on Rare Lung Disease at ERS Congress 2025 Read More